An Overview of Ventas's Earnings
Benzinga Insights 9 months ago
Earnings
Ventas (NYSE:VTR) is gearing up to announce its quarterly earnings on Thursday, 2026-02-05. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Ventas will report an earnings per share (EPS) of $0.41.
The market awaits Ventas's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Earnings Track Record
Last quarter the company beat EPS by $0.50, which was followed by a 6.56% increase in the share price the next day.
Here's a look at Ventas's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.38 | 0.34 | 0.82 | 0.80 |
| EPS Actual | 0.88 | 0.87 | 0.84 | 0.81 |
| Price Change % | 7.00 | 1.00 | -6.00 | 8.00 |
Insights Shared by Analysts on Ventas
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Ventas.
Analysts have given Ventas a total of 4 ratings, with the consensus rating being Outperform. The average one-year price target is $85.25, indicating a potential 9.73% upside.
Understanding Analyst Ratings Among Peers
The following analysis focuses on the analyst ratings and average 1-year price targets of Omega Healthcare Invts, Healthpeak Properties and Alexandria Real Estate, three prominent industry players, providing insights into their relative performance expectations and market positioning.
- Analysts currently favor an Neutral trajectory for Omega Healthcare Invts, with an average 1-year price target of $47.11, suggesting a potential 39.36% downside.
- Analysts currently favor an Neutral trajectory for Healthpeak Properties, with an average 1-year price target of $18.71, suggesting a potential 75.92% downside.
- Analysts currently favor an Neutral trajectory for Alexandria Real Estate, with an average 1-year price target of $61.0, suggesting a potential 21.48% downside.
Insights: Peer Analysis
The peer analysis summary presents essential metrics for Omega Healthcare Invts, Healthpeak Properties and Alexandria Real Estate, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.
| Company | Consensus | Revenue Growth | Gross Profit | Return on Equity |
|---|---|---|---|---|
| Ventas | Outperform | 20.44% | $619.08M | 0.55% |
| Omega Healthcare Invts | Neutral | 12.88% | $308.09M | 3.55% |
| Healthpeak Properties | Neutral | 1.92% | $413.95M | 1.51% |
| Alexandria Real Estate | Neutral | -4.50% | $496.33M | -6.74% |
Key Takeaway:
Ventas ranks first in revenue growth among its peers. It has the lowest gross profit and return on equity compared to its peers.
Delving into Ventas's Background
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
Key Indicators: Ventas's Financial Health
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Ventas's remarkable performance in 3 months is evident. As of 30 September, 2025, the company achieved an impressive revenue growth rate of 20.44%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: Ventas's net margin excels beyond industry benchmarks, reaching 4.44%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Ventas's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 0.55%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Ventas's ROA stands out, surpassing industry averages. With an impressive ROA of 0.25%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Ventas's debt-to-equity ratio is below the industry average at 1.03, reflecting a lower dependency on debt financing and a more conservative financial approach.
To track all earnings releases for Ventas visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.